4D Molecular Therapeutics (FDMT) Selling, General & Administrative (2020 - 2026)
4D Molecular Therapeutics (FDMT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.13 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 110.21 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 593.21 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2,715.95 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 161.89 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 347.92 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 247.47 Mn |
| 10 | 4D Molecular Therapeutics | 856.62 Mn | 495.28 Mn | - | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Mn |
| Mar 31, 2026 | 11.69 Mn |
| Dec 31, 2025 | 12.77 Mn |
| Sep 30, 2025 | 11.84 Mn |
| Jun 30, 2025 | 11.52 Mn |
| Mar 31, 2025 | 12.94 Mn |
| Dec 31, 2024 | 13.03 Mn |
| Sep 30, 2024 | 12.65 Mn |
| Jun 30, 2024 | 10.60 Mn |
| Mar 31, 2024 | 10.29 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | 9.11 Mn |
| Jun 30, 2023 | 8.79 Mn |
| Mar 31, 2023 | 7.99 Mn |
| Dec 31, 2022 | 8.47 Mn |
| Sep 30, 2022 | 8.06 Mn |
| Jun 30, 2022 | 8.17 Mn |
| Mar 31, 2022 | 8.23 Mn |
| Dec 31, 2021 | 7.33 Mn |
| Sep 30, 2021 | 8.19 Mn |